• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

US, Israeli officials deny approving sale of Israeli spyware firm to US investors

by December 21, 2024
written by December 21, 2024

By Raphael Satter and AJ Vicens

WASHINGTON (Reuters) – Officials in the United States and Israel have denied reports their countries had signed off on the sale of Israeli spyware maker Paragon to Florida-based AE Industrial Partners.

Over the past week, Israeli news outlets reported that Paragon, which was founded by former Israeli intelligence officers and backed by ex-Israeli Prime Minister Ehud Barak, had been bought by AE, an investment group focused on national security-related businesses. On Monday, a person familiar with the deal confirmed its broad outlines to Reuters.

Israeli media outlets, without citing sources, said the deal had secured the approval of American and Israeli officials.

But on Friday, a senior White House official said that was not true.

“The U.S. government never ‘approved’ this sale. This is a private transaction,” the official said. “There wasn’t some sort of green light given for this sale.”

The Israeli military also denied the reports, according to local media, which quoted the Defense Ministry saying that while Paragon had been in touch about the purchase, “the Ministry of Defense did not approve the sale” and officials were still studying the transaction.

Emails seeking comment from AE and Paragon were not immediately returned. The Israeli military has not responded to several requests for comment.

Paragon has already tried to make inroads in the U.S. surveillance market, although not without meeting roadblocks. In September, U.S. Immigration and Customs Enforcement signed a one-year contract worth $2 million with Paragon’s U.S. subsidiary, according to a report in Wired. But the White House official confirmed the contract had subsequently been paused and put under review.

ICE did not immediately return a message seeking comment.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
US government shutdown could cost travel sector $1 billion per week, disrupt holiday travel
next post
Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • A top Federal Reserve official says bleak jobs data backs the case for 3 rate cuts

      August 11, 2025
    • Bed Bath & Beyond relaunches with first store in Nashville, plans dozens more

      August 9, 2025
    • Lawsuit accuses Apple of stealing trade secrets to create Apple Pay

      August 9, 2025
    • Trump demands resignation of Intel CEO over alleged China ties

      August 7, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (593)
    • Stock (6,426)

    Latest News

    • A top Federal Reserve official says bleak jobs data backs the case for 3 rate cuts
    • Bed Bath & Beyond relaunches with first store in Nashville, plans dozens more

    Popular News

    • Mexico stocks higher at close of trade; S&P/BMV IPC up 1.81%
    • Morning Bid: 2024 bull run in home stretch, China ‘data dump’ eyed

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy